Galmed Pharmaceuticals (EOCN) EPS (Basic) (2013 - 2026)
Galmed Pharmaceuticals (EOCN) recorded EPS (Basic) of $23.40 in Q2 2026, up 9.1% from $21.44 a year earlier.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) EPS (Basic) (2013 - 2026) Analysis & Trends
On a TTM basis, Galmed Pharmaceuticals' EPS (Basic) came in at -$26.66 as of Jun 30, 2026; for FY2025, it came in at -$2.72.
- Across earlier years, EPS (Basic) came in at -$3.25 in FY2024, $239.60 in FY2023 (-76.6%), $1,023 in FY2022 (-46.2%) and $1,901 in FY2021 (-2.4%).
- The Q2 2026 figure is the highest quarterly EPS (Basic) since Q3 2024.
- On a year-over-year basis, EPS (Basic) rose in 1 of the last four quarters, with an average decline of 33.1%.
- Peak year-over-year performance for EPS (Basic) in the last five years was growth of 10.8% in Q3 2021, against a decline of 75.5% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -$16.42 (Q1 2026), -$49.91 (Q4 2025) and $16.26 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 1.68 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.87 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.40 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 4.34 |
| 10 | Galmed Pharmaceuticals | 422,361.40 | 422,361.40 | - | 23.40 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.40 |
| Mar 31, 2026 | -16.42 |
| Dec 31, 2025 | -49.91 |
| Sep 30, 2025 | 16.26 |
| Jun 30, 2025 | 21.44 |
| Mar 31, 2025 | -9.49 |
| Dec 31, 2024 | -40.27 |
| Sep 30, 2024 | 66.35 |
| Jun 30, 2024 | 38.79 |
| Mar 31, 2024 | -44.20 |
| Dec 31, 2023 | 69.88 |
| Sep 30, 2023 | 84.36 |
| Jun 30, 2023 | 91.24 |
| Mar 31, 2023 | -104.81 |
| Dec 31, 2022 | 151.15 |
| Sep 30, 2022 | 313.21 |
| Jun 30, 2022 | 218.61 |
| Mar 31, 2022 | -359.64 |
| Dec 31, 2021 | 436.27 |
| Sep 30, 2021 | 521.99 |
API Access
Galmed Pharmaceuticals EPS (Basic) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-basic&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-basic", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-basic&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();